[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 982
Citations 0
Invited Commentary
December 2018

Colorectal Cancer Control: Where Have We Been and Where Should We Go Next?

Author Affiliations
  • 1Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle
JAMA Intern Med. 2018;178(12):1658-1660. doi:10.1001/jamainternmed.2018.4627

Colorectal cancer (CRC) is the second leading cause of cancer death in the United States, but it does not have to be. Screening prevents CRC by finding precancerous lesions so they can be removed before they become cancerous. Screening can also detect CRC early and, when CRC is localized, 5-year survival is over 90%, with many patients cured. Five-year survival for late-stage CRC, however, is less than 20%.1

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words